Nureca Ltd. · NSE:NURECA
Nureca — Q1 FY2024 Earnings Presentation
17 slides from Nureca's earnings presentation, Aug 10, 2023
Slide 1: Letter to stock exchanges: Investor Presentation (Q1 FY24)
NURECA - www.nureca.com Dated-10.08.2023 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1 Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai-400051 S
Slide 2: Think. Feel. Create. Earnings Presentation August 2023
Think. Feel. Create. E a r n i n g s P r e s e n t a t i on August 2023
Slide 3: Disclaimer
Disclaimer NURECA LIMITED The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommenda
Slide 4: Nureca Limited at a glance
NURECA, 2021 ₹295Mn NURECA LIMITED is a leading Digital healthcare and wellness Listed On Stock Exchanges GMV For Q1FY24 Solutions provider ₹212Mn 76 CHRONIC Total Revenue For USFDA Approved DISEASES Q1FY24 Products LIFESTYLE ₹(2)Mn ₹(7)Mn & FITNESS ORTHOCARE EBITDA For Q1FY24 PAT For Q1FY24 Our MOT
Slide 5: Our growing customer base
Our growing customer base NURECA LIMITED CUSTOMER BASE (CUMULATIVE) * (000’) 12,182 12,441 Our customer base has grown 10,683 exceptionally over the last 4 years which is a result of remarkable 8,021 quality of our products that led to word-of-mouth marketing by our 39% loyal customer base. Currentl
Slide 6: Key Performance Indicators
Key Performance Indicators NURECA LIMITED (INR in Million) Revenue from Operations GMV Growth 503 368 278 366 255 338 317 212 212 295 17 % 13 % YoY YoY Q1'FY23 Q2'FY23 Q3'FY23 Q4'FY23 Q1'FY24 Q1'FY23 Q2'FY23 Q3'FY23 Q4'FY23 Q1'FY24 EBITDA PAT 10 3 Q1'FY23 Q2'FY23 Q3'FY23 Q4'FY23 Q1'FY24 Q1'FY23 Q2'F
Slide 7: Financials
Financials NURECA LIMITED (INR in Million) Particulars Q1'FY24 Q1'FY23 YoY Q4'FY23 QoQ Revenue from operations 212 255 -17% 212 0% Other Income 27 12 128% 21 24% Total Revenue 239 267 -10% 234 2% Cost of Goods Sold 144 171 -16% 143 1% Employee benefits expense 28 43 -35% 28 0% Other expenses 69 99 -
Slide 8: Financial Performance
Financial Performance NURECA LIMITED GMV of Q1’FY24 stood at Rs. 295mn as compared to Rs. 338mn in Q1’FY23, decrease of 13% Operating Revenue was Rs. 212mn in Q1’FY24 as compared to Rs. 255mn in Q1’FY23, decrease of 17% EBITDA of the Company stood at Rs.(2)mn in Q1’FY24 as compared to Rs. (46)
Slide 9: New Product Launches
New Product Launches NURECA LIMITED DR TRUST - EpsoMAX Body Wash and Foot Cream 08
Slide 10: New Product Launches
New Product Launches NURECA LIMITED DR TRUST - Contoured Cervical Pillow 09
Slide 11: Nureca Technologies - ISO 13485 and 9001 Certification
Nureca Technologies - ISO 13485 and 9001 Certification NURECA LIMITED Nureca Technologies Private Limited, a Wholly owned subsidiary of Nureca Limited, has obtained ISO 13485:2016 and ISO 9001:2015 certifications from notified body Intertek, for Nebulizers and Blood pressure monitors. These certific
Slide 12: Medical Products Manufactured by Nureca Technologies
Medical Products Manufactured by Nureca Technologies NURECA LIMITED BP Monitor Nebulizer Thermometer 011
Slide 13: Orthopedic Products Manufactured by Nureca Technologies
Orthopedic Products Manufactured by Nureca Technologies NURECA LIMITED Knee Pillow Coccyx Pillow Heat Belt Backrest Pillow Cervical Pillow 012
Slide 14: What Makes Nureca Different?
What Makes Nureca Different? NURECA LIMITED Product Quality •International standards quality and design of the products Regulatory Compliance •Our products are manufactured to be safe, accurate, long-lasting and compliant to national and international regulations. Our chronic monitoring devices are
Slide 15: Business Outlook
Business Outlook NURECA LIMITED • Strong focus on connected devices for remote patient monitoring ADDING PRODUCTS AND • Create a pipeline of innovative healthcare and wellness products CATEGORIES • A strong customer base for cross-selling of different products • Appointment of Mr. Rakesh Kumar, havi
Slide 16: Shareholder Information
Shareholder Information NURECA LIMITED Shareholding as on 30th June 2023 NRIs, 1.00% Bodies Corporate, HUF, 1.00% NSE Ticker NURECA 1.00% BSE Ticker 543264 IPO Listing Date 25th February 2021 Market Cap (INR Cr) 348 Resident Promoters, Individuals, 63.00% Share Price (INR) 348 34.00% (Shares Shares
Slide 17: Thank You
Thank. You. INVESTOR RELATIONS AT NURECA Gurvikram Singh cs@nureca.com Office No. 101, Udyog Bhavan, Sonawala Lane, Goregaon East, Mumbai, Maharashtra - 400063 Drtrust.in Drtrust360.com